Literature DB >> 32961206

A comparative proteomics analysis of the egg secretions of three major schistosome species.

Jack P Carson1, Mark W Robinson1, Michael H Hsieh2, James Cody3, Loc Le4, Hong You5, Donald P McManus5, Geoffrey N Gobert6.   

Abstract

Morbidity associated with hepatic and urogenital schistosomiasis stems primarily from the host immune response directed against schistosome eggs. When eggs become entrapped in host tissues, the development of fibrotic plaques drives downstream pathology. These events occur due to the antigenic nature of egg excretory/secretory products (ESPs). Both Schistosoma mansoni and S. japonicum ESPs have been shown to interact with several cell populations in the host liver including hepatocytes, macrophages, and hepatic stellate cells, with both immunomodulatory and pathological consequences. Several protein components of the ESPs of S. mansoni and S. japonicum eggs have been characterised; however, studies into the collective contents of schistosome egg ESPs are lacking. Utilising shotgun mass spectrometry and an array of in silico analyses, we identified 266, 90 and 50 proteins within the S. mansoni, S. japonicum and S. haematobium egg secretomes respectively. We identified numerous proteins with already established immunomodulatory activities, vaccine candidates and vesicle markers. Relatively few common orthologues within the ESPs were identified by BLAST, indicating that the three egg secretomes differ in content significantly. Having a clearer understanding of these components may lead to the identification of new proteins with uncharacterised immunomodulatory potential or pathological relevance. This will enhance our understanding of host-parasite interactions, particularly those occurring during chronic schistosomiasis, and pave the way towards novel therapeutics and vaccines.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Egg; Excretory/secretory protein; Proteomics; Schistosoma haematobium; Schistosoma japonicum; Schistosoma mansoni

Mesh:

Substances:

Year:  2020        PMID: 32961206      PMCID: PMC8059868          DOI: 10.1016/j.molbiopara.2020.111322

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  58 in total

1.  T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase.

Authors:  S R Reynolds; C E Dahl; D A Harn
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

Review 2.  Unconventional protein secretion - new insights into the pathogenesis and therapeutic targets of human diseases.

Authors:  Jiyoon Kim; Heon Yung Gee; Min Goo Lee
Journal:  J Cell Sci       Date:  2018-06-25       Impact factor: 5.285

3.  Molecular and enzymatic characterisation of Schistosoma mansoni thioredoxin.

Authors:  Heather M Alger; Ahmed A Sayed; Miguel J Stadecker; David L Williams
Journal:  Int J Parasitol       Date:  2002-09       Impact factor: 3.981

4.  Mapping the complement C1q binding site in Haemonchus contortus calreticulin.

Authors:  S Naresha; A Suryawanshi; M Agarwal; B P Singh; P Joshi
Journal:  Mol Biochem Parasitol       Date:  2009-02-24       Impact factor: 1.759

5.  A cloned major Schistosoma mansoni egg antigen with homologies to small heat shock proteins elicits Th1 responsiveness.

Authors:  Y Cai; J G Langley; D I Smith; D L Boros
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

Review 6.  Biological agents.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2012

Review 7.  Understanding Urogenital Schistosomiasis-Related Bladder Cancer: An Update.

Authors:  Kenji Ishida; Michael H Hsieh
Journal:  Front Med (Lausanne)       Date:  2018-08-10

8.  rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway.

Authors:  Liuting Chen; Qi Zhou; Ertao Liu; Jiali Zhang; Lian Duan; Dandan Zhu; Jinling Chen; Yinong Duan
Journal:  Parasit Vectors       Date:  2019-05-31       Impact factor: 3.876

9.  Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway.

Authors:  Jinling Chen; Tianhua Xu; Dandan Zhu; Jianxin Wang; Caiqun Huang; Lei Lyu; Bin Hu; Wei Sun; Yinong Duan
Journal:  Cell Death Dis       Date:  2016-07-28       Impact factor: 8.469

Review 10.  Schistosoma "Eggs-Iting" the Host: Granuloma Formation and Egg Excretion.

Authors:  Christian Schwartz; Padraic G Fallon
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

View more
  9 in total

1.  Transcriptomic and proteomic profiling of peptidase expression in Fasciola hepatica eggs developing at host's body temperature.

Authors:  Jana Ilgová; Jiří Vorel; Pavel Roudnický; Lucie Škorpíková; Martin Horn; Martin Kašný
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

2.  Proteomics Investigations of Potential Protein Biomarkers in Sera of Rabbits Infected With Schistosoma japonicum.

Authors:  Nian-Nian Bi; Song Zhao; Jian-Feng Zhang; Ying Cheng; Chen-Yang Zuo; Gang-Long Yang; Kun Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-12-22       Impact factor: 5.293

3.  Schistosoma mansoni Larval Extracellular Vesicle protein 1 (SmLEV1) is an immunogenic antigen found in EVs released from pre-acetabular glands of invading cercariae.

Authors:  Thomas A Gasan; Marije E Kuipers; Grisial H Roberts; Gilda Padalino; Josephine E Forde-Thomas; Shona Wilson; Jakub Wawrzyniak; Edridah M Tukahebwa; Karl F Hoffmann; Iain W Chalmers
Journal:  PLoS Negl Trop Dis       Date:  2021-11-18

4.  Chromosome-level genome of Schistosoma haematobium underpins genome-wide explorations of molecular variation.

Authors:  Andreas J Stroehlein; Pasi K Korhonen; V Vern Lee; Stuart A Ralph; Margaret Mentink-Kane; Hong You; Donald P McManus; Louis-Albert Tchuem Tchuenté; J Russell Stothard; Parwinder Kaur; Olga Dudchenko; Erez Lieberman Aiden; Bicheng Yang; Huanming Yang; Aidan M Emery; Bonnie L Webster; Paul J Brindley; David Rollinson; Bill C H Chang; Robin B Gasser; Neil D Young
Journal:  PLoS Pathog       Date:  2022-02-15       Impact factor: 6.823

Review 5.  Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects.

Authors:  Adebayo J Molehin; Donald P McManus; Hong You
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

6.  Immunotherapy for type 1 diabetes mellitus by adjuvant-free Schistosoma japonicum-egg tip-loaded asymmetric microneedle patch (STAMP).

Authors:  Haoming Huang; Dian Hu; Zhuo Chen; Jiarong Xu; Rengui Xu; Yusheng Gong; Zhengming Fang; Ting Wang; Wei Chen
Journal:  J Nanobiotechnology       Date:  2022-08-13       Impact factor: 9.429

7.  Clinical helminth infections alter host gut and saliva microbiota.

Authors:  Geoffrey N Gobert; Louise E Atkinson; Andrea Lokko; Tippayarat Yoonuan; Orawan Phuphisut; Akkarin Poodeepiyasawat; Nirundorn Homsuwan; Angela Mousley; Poom Adisakwattana
Journal:  PLoS Negl Trop Dis       Date:  2022-06-08

Review 8.  Trematode Proteomics: Recent Advances and Future Directions.

Authors:  Adam P S Bennett; Mark W Robinson
Journal:  Pathogens       Date:  2021-03-16

9.  Schistosoma mansoni Adult Worm Protective and Diagnostic Proteins in n-Butanol Extracts Revealed by Proteomic Analysis.

Authors:  Guidenn Sulbarán; Giovani C Verissimo da Costa; Sandra Losada; José M Peralta; Italo M Cesari
Journal:  Pathogens       Date:  2021-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.